Market Newsdesk

NEW YORK, NY, March 03, 2021 (GLOBE NEWSWIRE) — SPYR Technologies (OTC Pink: SPYR) and its wholly owned subsidiary, Applied MagiX, are meticulously following a roadmap they created for themselves to compete in the Apple^® HomeKit^® space.  Last quarter, SPYR acquired Applied MagiX, a registered Apple developer, and reseller of Apple ecosystem compatible products, to join the growing multi-billion-dollar smart home market, a market expected by forecasters to balloon into the $100s of billions of dollars over the next 4 to 6 years.

When asked what sold him on acquiring Applied MagiX, SPYR’s Chief Executive Officer (CEO), James R. Thompson, said the company made the acquisition after a great deal of due diligence on the company’s future plans and the man at the helm of Applied MagiX, Dr. Harald Zink, its CEO and Founder.  “In short, it was Dr. Zink’s experience and vision for Applied MagiX.  He has product development, engineering, and marketing experience, and he brings his wealth of experience and relationships with him, which he intends to make the most of to assist SPYR in its endeavor.”

Thompson pointed to Dr. Zink’s long history with Apple products dating back to 1989 with his work on a real-time video digitizer card (Vision Plus Enhanced) for the Apple IIGS, and his relationships with Apple executives, which resulted in long-time collaborations with various manufacturers and developers, as well as Apple directly, over the past 25 years as reasons that Dr. Zink and his company, Applied MagiX, are ideal to help SPYR vie for its share of the smart home market.

So, with Dr. Zink and Applied MagiX now under the SPYR umbrella, what is the near and long-term plan to begin growing SPYR’s footprint in this market?  According to both Jim Thompson and Dr. Zink, the companies have developed a multi-pronged approach to building, evolving, and growing Applied MagiX.   

“We planned and budgeted for an initial period of establishing the basic infrastructure, performing competition research, conducting product research and sourcing.  Acquiring our developer license, the Apple ‘MFi’ license (Made for iPhone, iPad, etc.), and establishing a presence in Hong Kong to facilitate our work with our development and production partners in China were all part of that.”

The initial basic roadmap will see Applied MagiX sourcing various accessory and convenience products that will fall under the company’s newly named, Truly Convenient™ sub-brand, including HomeKit products, to offer the public through the company’s online store.  

While discussing the products that the company will be sourcing, Dr. Zink said, “These products will be vetted as the sort of products we want to use ourselves.  These products will be USB chargers, automobile USB chargers, lightning, and USB-C cables, and will be part of our proprietary Truly Convenient sub-brand that we created specifically for this purpose.  We are also aiming to provide some Apple CarPlay devices, which will be geared towards improving the smart interfaces in modern cars.”

This initial product rollout will generate revenue for the company, establish distribution channels, and test the company’s online store, which is part of this buildout phase that will see a reorganization of the company’s website to include an online shopping experience, a more comprehensive and active blog, along with a support and discussion forum for its customers and fellow Apple-product enthusiasts.

Dr. Zink, continuing to lay out the roadmap, said, “Our second phase involves releasing proprietary products under our own brand.  Product development timelines push these products out to roughly 6 months after initial development begins, so these products should start to emerge this Fall.  

“What I can say about our proprietary product line is that those products will be, almost exclusively, HomeKit-geared products.  Our product line will be composed of items that we know are in demand, as well as those that provide conveniences. So, our product line will provide cameras that support HomeKit Secure Video, security devices to allow monitoring your home and alerting you to intrusions, as well as associated accessories for existing popular Smart Home products.”

It should be clear that Applied MagiX focuses on the Smart Home market, but specifically as it relates to Apple consumers (HomeKit users), which covers a wide range of smart devices that can connect to HomeKit.  Users have lots of options, including door locks, lights, power plugs, cameras, thermostats, motion sensors, window shades, you name it, and the Home app on your Apple internet-connected devices can handle all of it in one place.

Dr. Zink says that the company focuses on the Apple HomeKit consumer market simply because most of the other market players are “in a sandbox that is hopelessly overpopulated with mostly sub-par products that offer little to no profit margin,” and it’s not a market that Applied MagiX is interested in.

“The Apple HomeKit consumer market offers great opportunities, not only because it is a market that appreciates premium products, but also because this market segment is still underserved.  We see several items lacking in that market, which we hope to be able to serve.

“This leads to our product goals—developing Applied MagiX-branded products that don’t just fit the HomeKit space, but that provide a unique edge through unique features.  While we are not interested in competing in the low-price space, we expect to offer some products that aim to provide a premium experience at a competitive price.  Thus, instead of competing on lowest prices, we’d rather provide additional features, abilities or performance with our products.”

SPYR won’t stop at just the Apple HomeKit market either.  The acquisition of Applied MagiX was merely the company’s first shot across the bow into the technology sector.  And SPYR’s CEO says that his company has its eye to the future and on other technologies as well.

“Another area of the technology industry that is experiencing rapid growth has products for the home that have an AI or artificial intelligence component to them, as well as real-time locating systems (RTLS) for tracking personnel and assets, and wearable emergency alert systems, utilizing active Radio Frequency Identification (RFID) technology in commercial applications.  While we lay the foundation for Applied MagiX and its initial sales, we are also exploring opportunities to bring in such products under the SPYR Technologies umbrella.”

Read SPYR Technologies’ press releases which outline its productive Q4 2020, its acquisition of Applied MagiX, the plan to move the company forward in 2021 and beyond, and the funding commitments the company has secured at https://www.nasdaq.com/market-activity/stocks/spyr/press-releases

About SPYR Technologies

SPYR Technologies is a technology company that, through its subsidiary, Applied MagiX Inc., develops and resells Apple^® ecosystem compatible products with an emphasis on the growing multi-billion-dollar smart home market.  SPYR continues to identify and target acquisitions that will grow its footprint in the industry and expand the products it offers consumers, including companies developing artificial intelligence and smart-technology products.

About Stock Market Media Group

Stock Market Media Group is a news & media content development IR firm offering a platform for corporate stories to unfold in the media with press releases, feature news articles, corporate videos, radio-style CEO interviews, and research reports.

This article was written based on publicly available information. Stock Market Media Group may, from time to time, include our own opinions about the companies, their business, markets, and opportunities in our articles. Any opinions we may offer about any of the companies we write about are solely our own and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice, or construed or interpreted as research. Any investment decisions you may make concerning any of the securities we write about are solely your responsibility based on your own due diligence. Our publications are provided only as an informational aid, and as a starting point for doing additional independent research. We encourage you to invest carefully and read the investor information available at the website of the U.S. Securities and Exchange Commission at www.sec.gov, where you can also find all of SPYR Technologies’ filings and disclosures. We also recommend, as a general rule, that before investing in any securities, you consult with a professional financial planner or advisor, and you should conduct a complete and independent investigation before investing in any security after prudent consideration of all pertinent risks.  We are not a registered broker, dealer, analyst, or advisor. We hold no investment licenses and may not sell, offer to sell, or offer to buy any security. Our publications about SPYR Technologies are not a recommendation to buy or sell a security.

Should Stock Market Media Group and its management own shares in the profiled company, they may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought or issued at any given time including shortly after the release of the company’s profile. Section 17(b) of the 1933 Securities and Exchange Act requires publishers who distribute information about publicly traded securities for compensation, to disclose who paid them, the amount, and the type of payment.  Under the Securities Act of 1933, Section 17(b), Stock Market Media Group discloses that it was remunerated fifteen-thousand dollars, paid for by a third party via bank wire, for its published content related to SPYR Technologies.

In February 2015, SPYR agreed to issue to us 250,000 shares of SPYR’s Restricted Common Stock. Our rights to sell any of this Restricted Common Stock are subject to prior compliance with all U.S. Securities Laws, including but not limited to Rule 144. Further, our sale of any of the Restricted Common Stock is subject to a volume restriction providing that we may only sell 5,000 shares daily for every 250,000 shares of daily trading volume.  All shares have been held for the requisite period under Rule 144 and were eligible to be sold immediately upon reaching the requisite holding period without further notice.

Stock Market Media Group and its management never accept compensation in free-trading shares for its marketing services of the company being profiled, however third parties that have compensated Stock Market Media Group may hold free-trading shares of the company being profiled and could very well be selling shares of the company’s stock at the same time the content is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

For more information: www.stockmarketmediagroup.com.

Contact:

Stock Market Media Group

[email protected]

PRINCETON, N.J., March 03, 2021 (GLOBE NEWSWIRE) — Indegene, a global enterprise healthtech solutions company and ConTIPI Medical Ltd, an innovator in the field of providing non-surgical and disposable solutions for women with various pelvic floor disfunctions, today announced a partnership to bring a new device to the market to help women suffering from Pelvic Organ Prolapse (POP).

The US FDA states that POP occurs when the pelvic floor’s tissues and muscles can no longer support its organs. This causes a drop or prolapse of the pelvic organs from their normal position into the vagina and even outside the body. POP is prevalent in approximately 54 million American women over 20 years old⁽¹⁾. The current treatment methods include mostly either an invasive surgery with up to 30% failure rate, or the use of non-invasive pessaries which are vaginal devices that currently require a physician’s care to insert and remove.

ConTIPI’s ProVate device is a ready-to-use device. It is inserted vaginally by the user herself using an easy-to-use applicator. Following insertion, the applicator is discarded, and the device opens within the vagina and provides support to predefined specific sites along the vaginal walls. At the end of usage, the user pulls a string which collapses the device back into a small dimension for comfortable removal and disposal, very similar to the use of a menstrual tampon. Another device may be inserted immediately or at a later stage – at the user’s discretion. This innovation empowers women to take control over their health and treatment, and to decide when, where and if they want to use or remove the device. The device has a 510(k) clearance from FDA for marketing in the USA and has been granted the CE mark for marketing in Europe.

Indegene is partnering with ConTIPI Medical Ltd to bring this innovation to women in the US affected by POP with various degrees of prolapse. Indegene will be supporting ConTIPI in the process of educating both healthcare providers and affected women on ProVate’s unique benefits and assisting ConTIPI to launch the device in the market. Indegene brings a unique co-commercialization model to enable ConTIPI to fulfill its mission to bring unique pelvic floor solutions to women.

The ProVate device allows women to control their healthcare and provides them the freedom to choose how and when to manage this medical problem.

ConTIPI is known for innovation in the women’s healthcare space. ConTIPI invented and developed the Poise Impressa Device for stress urinary incontinence in women, which was acquired by Kimberly Clark Worldwide.  Dr. Elan Ziv, CEO & Medical Director at ConTIPI says, “Following the success of the Poise Impressa device for Stress Urinary Incontinence, we are excited to introduce ProVate to empower women suffering from POP and encourage them to take control of their lives. In Indegene, we found a natural partner who helps us navigate the complex process from product innovation to patient adoption. At ConTIPI, we take pride in our Urogynecology expertise and innovation capabilities. It is great to have a partner that helps us focus on our strengths, while enabling us to get our innovation in the hands of the women who need this treatment. Indegene’s technology-led, end-to-end commercialization process and unique pay-for-performance business model is a true blessing for emerging MedTech enterprises as ours.”

Gaurav Kapoor, Co-Founder and Executive Vice President at Indegene adds, “We are very proud to play our part in enabling ConTIPI’s goal to empower and alleviate women suffering from POP through the ProVate device. We believe the healthcare industry needs commercial innovation as much as product innovation. Through a modern, digital-led approach and a differentiated business model, we stand ready to help ConTIPI launch ProVate faster and take it to a broad segment of women having to live with POP.”

Bourne Partners served as the advisor to ConTIPI.

About ConTIPI Medical

ConTIPI Medical, and its associate company ConTIPI Limited, both located at the Caesarea Industrial Park in Israel, provide non-surgical and disposable vaginal solutions for women with various Pelvic Floor Disorders (PFDs). To learn more, please visit www.contipi.com

About Indegene

Indegene is a global enterprise healthtech solutions company. It accelerates medical and commercial outcomes, and personalizes experiences by applying deep medical knowledge and verticalized technology across the healthcare value chain. Some of the largest global healthcare enterprises lean on its domain experts for an agile, customized, enduring partnership. With over 3,000 Indegeons in the US, Europe, China, Japan and India, it has delivered over 100 strategic engagements, fully commercialized about $2 billion portfolio, and created over 1 million medical and commercial content assets. To learn more, please visit www.indegene.com

For media enquiries, please contact:

Shefali Kotnala
[email protected]
Phone: +91 98863 78407

(1)    Source: Trinity Partners Inc. Boston, MA, USA, August 2015 

FREEHOLD, N.J., March 03, 2021 (GLOBE NEWSWIRE) — NERD Focus™, a leading focus beverage recently acquired by BevUSA, today announces its expansion into Wisconsin, adding to its local availability in addition to Texas, New Jersey, Las Vegas and Nashville. As part of the rollout, NERD has partnered with Bill’s Distributing, Wisconsin’s quality beverage distributor, to release its mental acuity drink NERD Focus in Wisconsin-based Festival Foods – a family and employee-owned grocery company. Made with powerful vitamins, nootropics and performance-boosting nutrients, NERD Focus is the world’s first “Think Drink” formulated to increase clarity and concentration, boost memory and cognition and support overall brain health.

“With the regional success NERD has seen in both large and small stores, growing NERD Focus’ presence in retailers across Wisconsin was the next step for the brand,” said CEO of BevUSA, Howard Davner. “Working alongside Bill’s Distributing to initiate this rollout felt like a perfect match. They service many local Wisconsin stores that have such a loyal customer base, and the entire team centers their work around customer service, which is important to us at NERD Focus.”

In addition to its presence in 40+ Festival Foods locations, Bill’s Distributing will also be bringing NERD Focus to smaller grocery chains and convenience stores across Wisconsin to reach its growing customer base. The vitamin-based focus drink is available in Green Original and Blue Zero Calorie, offering consumers a smarter and safer alternative to energy drinks with a refreshing citrus taste packed with natural ingredients. The drinks contain both nootropics and adaptogens, creating a proprietary formula healthier than traditional highly-caffeinated and sugary energy drinks.

“When choosing what new brands to start working with, we always consider how they can bring added value to our customers,” said Cory Giertz, Vice President of Sales at Bill’s Distributing. “NERD Focus uses vitamins and other nutrients that aren’t commonly found in traditional energy drinks, and Bill’s Distributing immediately loved that unique differentiator. We think the stores we service will thoroughly enjoy this new option and we look forward to continuing our partnership with NERD.”

For more information on NERD Focus or to purchase online, visit: www.nerdfocus.com. To find a participating Festival Foods near you, use the NERD Focus store locator: https://nerdfocus.com/pages/store-locator.

About NERD™:

In 2006, a student at the University of Texas at San Antonio on the path to med school witnessed his colleagues rely on highly caffeinated energy drinks with potentially dangerous ingredients to increase mental stamina and focus. With the help of his professors, they created a “Think Drink” and within weeks, had students lining up outside of his campus apartment to purchase his new drink – NERD Focus. NERD™ became established and began selling on college campuses in Texas directly to students, building a grassroots network of distributors and fans. After creating a very loyal following at Texas universities and local retailers, Nerd was acquired by Beverage USA to invest into scaling the beverage brand nationwide.

About Bill’s Distributing:

Bill’s Distributing is a family owned and operated beverage distributor that has been in business since 1954. While nestled away in the small town of Menomonie, WI, Bill’s is well known throughout the Midwest for their best-in-class market execution. At Bill’s, we enjoy helping our customers grow their business and strive to provide service that exceeds their expectations. We truly live our values everyday … “Quality in everything we do & superior service that sets us apart.”

Media Contact:

Brenna Byrne
Uproar PR for NERD™ Focus
[email protected]
312-607-8117

FORT WORTH, TX, March 03, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — ADM Endeavors, Inc. (OTCQB: ADMQ) is pleased to announce that its revenue for January-February 2021 increased by approximately 10.9% compared to the Company revenue in the same period in 2020.

ABOUT ADMQ: Since 2010, our wholly owned subsidiary, Just Right Products, Inc., has been consistently profitable, with sales topping $5.1 million in 2020. The Company sells “Anything With A Logo” on its website, JustRightProducts.com, developing products ranging from unique business cards to coffee cups, T-shirts to boots, with tens of thousands of other unique products from which to select. The Company operates a diverse vertical integrated business in the Dallas/Fort Worth area, consisting of a retail sales division, screen print production, embroidery production, digital production, import wholesale sourcing, and uniforms.

Forward Looking Statement:

This press release contains certain “forward-looking statements,” as defined in the United States PSLRA of 1995, that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management’s current expectations. The economic, competitive, governmental, technological and other factors identified in the Company’s previous filings with the Securities and Exchange Commission may cause actual results or events to differ materially from those described in the forward-looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact: ADM Endeavors, Inc.

https://www.admendeavors.com

Paul Knopick

[email protected]

940.262.3584

Attachment

• ADMQ-revenue200 (1)

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICE OR FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) — Westhaven Gold Corp. (TSX-V:WHN) (“Westhaven” or the “Company”) is pleased to announce that it has closed its previously announced bought deal financing (the “Offering”). Pursuant to the Offering, Westhaven issued 21,378,500 units of the company (the “Units”), including 2,788,500 Units issued in connection with the exercise in full of the over-allotment option granted to Raymond James Ltd. in connection with the Offering, at a price of C$0.70 per Unit for gross proceeds of C$14,964,950.

Each Unit consists of one common share of the Company and one-half common share purchase warrant (each whole common share purchase warrant, a “Warrant”). Each Warrant will entitle the holder to acquire one common share of the Company for an exercise price of C$1.00 per share for a period of two years from the Closing Date. The Warrants will be listed on the TSX Venture Exchange with trading commencing on March 5, 2021. The Warrants were issued under a warrant indenture dated March 3, 2021, a copy of which is available on the Company’s profile on SEDAR.

‎The net proceeds from the Offering will be used to fund the exploration and development of the Company’s mining properties in British Columbia including Shovelnose, drilling to complete a maiden resource estimate, working capital and general corporate purposes.

The Units were offered by way of short form prospectus in each of the provinces of Canada (except the Province of Quebec), pursuant to National Instrument 44-101 – Short Form Prospectus Distributions.

Westhaven benefits from the B.C. Mining Exploration Tax Credit (METC) which is a permanent incentive to support investment in mining. The METC is a refundable B.C. income tax credit for eligible individuals and corporations conducting grassroots mineral exploration in B.C. and is worth 30% of qualified mining exploration expenditures.

The securities offered in the Offering have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or any U.S. state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the “United States” or “U.S. persons” (as such terms are defined in Rule 902 of Regulation S under the U.S. Securities Act) absent registration under the U.S. Securities Act and applicable U.S. state securities laws or compliance with the requirements of an exemption therefrom. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities, nor will there be any sale of these securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful.

On behalf of the Board of Directors
WESTHAVEN GOLD CORP.

“Gareth Thomas”

Gareth Thomas, President, CEO & Director

About Westhaven:

Westhaven is a gold-focused exploration company advancing the high-grade discovery on the Shovelnose project in Canada’s newest gold district, the Spences Bridge Gold Belt. Westhaven controls 37,000 hectares (370 square kilometres) with four 100% owned gold properties spread along this underexplored belt. The Shovelnose property is situated off a major highway, in close proximity to power, rail, large producing mines, and within commuting distance from the city of Merritt, which translates into low cost exploration. Westhaven is committed to the highest standards of environmental and social responsibility with a focus on generating positive outcomes and returns to all stakeholders. Westhaven trades on the TSX Venture Exchange under the ticker symbol WHN. For further information, please call 604-336-6921 or visit Westhaven’s website at

www.westhavengold.com

Cautionary note regarding forward-looking statements

This news release contains certain “forward looking statements” and certain “forward-looking information” as defined under applicable Canadian and U.S. securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as “may”, “will”, “should”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar terminology. The forward-looking information contained herein is provided for the purpose of assisting readers in understanding management’s current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes.

Forward-looking statements and information include, but are not limited to, statements in respect of the proposed Offering including the proposed use of proceeds, the closing date of the Offering and receipt of regulatory and stock exchange approvals.

Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual actions, events or results to be materially different from those expressed or implied by such forward-looking information, including but not limited to: the requirement for regulatory approvals; enhanced uncertainty in global financial markets as a result of the current COVID-19 pandemic; unquantifiable risks related to government actions and interventions; stock market volatility; regulatory restrictions; and other related risks and uncertainties.

Forward-looking information are based on management of the parties’ reasonable assumptions, estimates, expectations, analyses and opinions, which are based on such management’s experience and perception of trends, current conditions and expected developments, and other factors that management believes are relevant and reasonable in the circumstances, but which may prove to be incorrect.

Westhaven undertakes no obligation to update forward-looking information except as required by applicable law. Such forward looking information represents management’s best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.

SPARTA, N.J., March 03, 2021 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform designed to provide more effective and safer products, today announced the pricing of an underwritten public offering of 7,875,000 shares of its common stock, offered at a price of $8.00 to the public. Additionally, the Company has granted the underwriters a 30-day option to purchase up to an additional 1,181,250 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares in the offering are being offered by the Company. The offering is expected to close on or about March 5, 2021, subject to customary closing conditions. The gross proceeds to the Company from this offering are expected to be approximately $63 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. This amount assumes no exercise of the underwriters’ option.

The Company intends to use the net proceeds from this offering for general corporate purposes. General corporate purposes may include additions to working capital and capital expenditures.

Raymond James & Associates, Inc. and Oppenheimer & Co. Inc. are acting as joint book-running managers for the offering.

This offering is being made pursuant to an effective shelf registration statement on Form S-3 (No. 333-230478) previously filed with the U.S. Securities and Exchange Commission (the “SEC”) and declared effective by the SEC on April 4, 2019. A preliminary prospectus supplement relating to the offering was filed with the SEC on March 2, 2021 and is available on the SEC’s website at www.sec.gov. The final prospectus supplement relating to the offering will be filed with the SEC and will also be available on the SEC’s web site at www.sec.gov.  Before investing in the offering, you should read the prospectus supplement and the accompanying prospectus in their entirety as well as the other documents that the Company has filed with the SEC that are incorporated by reference in the prospectus supplement and the accompanying prospectus, which provide more information about the Company and the offering. Copies of the final prospectus supplement and accompanying prospectus , when available, may also be obtained from Raymond James & Associates, Inc., Attention: Equity Syndicate, 880 Carillon Parkway, St. Petersburg, Florida 33716, by telephone at (800) 248-8863 or by e-mail at [email protected]; or Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY, 10004, by telephone at (212) 667-8055, or by email at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About PLx Pharma Inc.

PLx Pharma Inc. is a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the gastrointestinal (GI) tract. PLx believes this platform has the potential to improve the absorption of many drugs currently on the market or in development, and to reduce the risk of stomach erosions and ulcers associated with certain drugs.

To learn more about PLx Pharma Inc. and its pipeline, please visit www.plxpharma.com.

Forward-Looking Statements

Any statements made in this press release relating to future financial or business performance, conditions, plans, prospects, trends, or strategies and other financial and business matters, including without limitation, the prospects for commercializing or selling any products or drug candidates are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, when or if used in this press release, the words “may,” “could,” “should,” “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “predict” and similar expressions and their variants, as they relate to PLx may identify forward-looking statements. PLx cautions that these forward-looking statements are subject to numerous assumptions, risks, and uncertainties, which change over time. Important factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks and uncertainties, including the failure by PLx to secure and maintain relationships with collaborators; risks relating to clinical trials; risks relating to the commercialization, if any, of PLx’s proposed product candidates (such as marketing, regulatory, product liability, supply, competition, and other risks); dependence on the efforts of third parties; dependence on intellectual property, risks that PLx may lack the financial resources and access to capital to fund proposed operations. Further information on the factors and risks that could affect PLx’s business, financial conditions and results of operations are contained in PLx’s filings with the U.S. Securities and Exchange Commission (“SEC”), which are available at www.sec.gov. Other risks and uncertainties are more fully described in PLx’s Form 10-K for the year ended December 31, 2019 filed with the SEC on March 13, 2020, and in other filings that PLx has made or will make going forward. The forward-looking statements represent PLx’s estimate as of the date hereof only, and PLx specifically disclaims any duty or obligation to update forward-looking statements.

Contact
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: [email protected]
Source: PLx Pharma Inc.

BASKING RIDGE, N.J., March 03, 2021 (GLOBE NEWSWIRE) — The Board of Directors at Verizon Communications Inc. (NYSE, Nasdaq: VZ) today declared a quarterly dividend of 62.75 cents per outstanding share, unchanged from the previous two quarters. The quarterly dividend is payable on May 3, 2021, to Verizon shareholders of record at the close of business on April 9, 2021.

Verizon has approximately 4.1 billion shares of common stock outstanding. The company made $10.23 billion in cash dividend payments in 2020.

Verizon Communications Inc. (NYSE, Nasdaq: VZ) was formed on June 30, 2000 and is one of the world’s leading providers of technology, communications, information and entertainment products and services. Headquartered in New York City and with a presence around the world, Verizon generated revenues of $128.3 billion in 2020. The company offers data, video and voice services and solutions on its award-winning networks and platforms, delivering on customers’ demand for mobility, reliable network connectivity, security and control.

VERIZON’S ONLINE MEDIA CENTER: News releases, stories, media contacts and other resources are available at https://www.verizon.com/about/media-center. News releases are also available through an RSS feed. To subscribe, visit www.verizon.com/about/rss-feeds/.

Media contact:

Eric Wilkens
[email protected]
201.572.9317
@ericwilkens